Supran Bryan

Alnylam Pharmaceuticals Inc · EVP

Supran Bryan is listed in filings as EVP at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 4, 2026, including 2 public disclosures. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY). The current snapshot covers public activity from Mar 4, 2026. Reported amounts are shown as $1.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.